http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20090109055-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-235 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate | 2009-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20090109055-A |
| titleOfInvention | Liver fibrosis inhibitor |
| abstract | It inhibits hepatic fibrosis that occurs continuously in chronic hepatitis, thereby providing a safe hepatic fibrosis inhibitor.n n n General formulan n n n n n n n In the formula, R 1 is an alkyl group having 4 to 8 carbon atoms, R 2 represents a hydrogen atom, an alkylcarbonyl group having 2 to 6 carbon atoms or an alkoxycarbonyl group having 2 to 6 carbon atoms or a cyclodextrin clathrate thereof. It is a hepatic fibrosis inhibitor characterized by including a oxyquinone derivative as an active ingredient. |
| priorityDate | 2008-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.